Date: 2015-09-02
Type of information: Collaboration agreement
Compound:
Company: Therametrics (Switzerland) Accelovance (USA - MD)
Therapeutic area: Technology - Services
Type agreement: collaboration clinical research
Action mechanism:
Disease:
Details: * On September 2, 2015, Therametrics announced that it has signed a general collaboration contract with Accelovance, an industry award-winning Contract Research Organization (CRO) focused primarily in oncology, vaccines, and general medicine and headquartered in Rockville, MD, USA. Under the proposed terms the two companies will cooperate under a master service agreement to provide services in the clinical research area.
Financial terms:
Latest news:
